Antibodies under a microscope

PX-TA1293

Futuximab Biosimilar – Anti-EGFR domain III / ERBB1 mAb – Research Grade

Description

Futuximab Biosimilar - Anti-EGFR domain III / ERBB1 mAb - Research Grade

Target

EGFR domain III / ERBB1

Target Alias Name

Futuximab/DS 992/Sym 004 (combination of modotuximab and futuximab)/EGFR domain III / ERBB1/anti-EGFR domain III / ERBB1

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression